Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention-Reference-Cited by-同舟云学术

Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention

Published:2019-12-30 Issue: Volume: Page:
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Li Qing^ORCID,Peterson Norman,Hanna Richard N.,Kuszpit Kyle,White Jason^ORCID,Allen Kevin L.,Barnes Arnita,Rickert Keith W.,Shan Lu,Wu Herren,Dall’Acqua William F.,Tsui Ping,Borrok M. Jack

Funder

AstraZeneca

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00939

Reference35 articles.

1. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

2. Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade

3. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

4. Paricalcitol for reduction of albuminuria in diabetes

5. Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein and peptide-based renal targeted drug delivery systems;Journal of Controlled Release;2024-02

2. Surface modification of lipid nanoparticles for gene therapy;The Journal of Gene Medicine;2023-12-03

3. Advanced Drug Delivery Systems for Renal Disorders;Gels;2023-02-01

4. PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis;Heliyon;2022-08

5. Endothelial Transcytosis in Acute Lung Injury: Emerging Mechanisms and Therapeutic Approaches;Frontiers in Physiology;2022-03-31